These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 7895309)

  • 1. Agents for the treatment of overactive detrusor. VIII. Synthesis and pharmacological properties of 4,4-diphenyl-2-cycloalkenylamines including FK584 and 3,3- or 4,4-diphenylcycloalkylamines.
    Taniguchi K; Okumura K; Take K; Tsubaki K; Terai T; Nakanishi I; Shiokawa Y
    Chem Pharm Bull (Tokyo); 1995 Jan; 43(1):71-7. PubMed ID: 7895309
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Agents for the treatment of overactive detrusor. V. Synthesis and inhibitory activity on detrusor contraction of N-tert-butyl-4,4-diphenyl-2-cyclopentenylamine.
    Take K; Okumura K; Tsubaki K; Taniguchi K; Terai T; Shiokawa Y
    Chem Pharm Bull (Tokyo); 1996 Oct; 44(10):1858-64. PubMed ID: 8904812
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Agents for the treatment of overactive detrusor. IX. Synthesis and pharmacological properties of metabolites of N-tert-Butyl-4,4-diphenyl-2-cyclopentenylamine (FK584) in human urine.
    Taniguchi K; Miyao Y; Yamano K; Yamamoto T; Terai T; Kusunoki T; Tsubaki K; Shiokawa Y
    Chem Pharm Bull (Tokyo); 1996 Jun; 44(6):1188-95. PubMed ID: 8814950
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Agents for the treatment of overactive detrusor. VII. Synthesis and pharmacological properties of 2,3- and 3,4-diphenylcyclopentylamines, 2,3-diphenyl-2-cyclopentenylamines, and related compounds.
    Taniguchi K; Tsubaki K; Take K; Okumura K; Terai T; Shiokawa Y
    Chem Pharm Bull (Tokyo); 1994 Apr; 42(4):896-902. PubMed ID: 8020125
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Asymmetric synthesis and determination of the absolute configuration of FK584, an agent for the treatment of overactive detrusor.
    Take K; Okumura K; Tsubaki K; Taniguchi K; Shiokawa Y
    Chem Pharm Bull (Tokyo); 2000 Dec; 48(12):1903-7. PubMed ID: 11145141
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacological effects of tolterodine on human isolated urinary bladder.
    Yono M; Yoshida M; Wada Y; Kikukawa H; Takahashi W; Inadome A; Seshita H; Ueda S
    Eur J Pharmacol; 1999 Mar; 368(2-3):223-30. PubMed ID: 10193658
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Agents for the treatment of overactive detrusor. VI. Synthesis and pharmacological properties of acetamide derivatives bearing cyclic amines in N-substituents.
    Taniguchi K; Tsubaki K; Mizuno H; Take K; Okumura K; Terai T; Shiokawa Y
    Chem Pharm Bull (Tokyo); 1994 Jan; 42(1):74-84. PubMed ID: 8124770
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Different responses to drugs against overactive bladder in detrusor muscle of pig, guinea pig and mouse.
    Wüst M; Averbeck B; Reif S; Bräter M; Ravens U
    Eur J Pharmacol; 2002 Nov; 454(1):59-69. PubMed ID: 12409006
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Agents for the treatment of overactive detrusor. IV. Synthesis and structure-activity relationships of cyclic analogues of terodiline.
    Take K; Okumura K; Tsubaki K; Terai T; Shiokawa Y
    Chem Pharm Bull (Tokyo); 1993 Mar; 41(3):507-15. PubMed ID: 8477501
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Berberine improves neurogenic contractile response of bladder detrusor muscle in streptozotocin-induced diabetic rats.
    Ren LM; Zhuo YJ; Hao ZS; He HM; Lu HG; Zhao D
    J Ethnopharmacol; 2013 Dec; 150(3):1128-36. PubMed ID: 24184080
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effect of terodiline hydrochloride in isolated rabbit detrusor].
    Abe M; Ono Y; Yamazaki Y; Ujiie A; Ikeda S
    Nihon Yakurigaku Zasshi; 1987 Jul; 90(1):33-40. PubMed ID: 3653802
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of the SK/IK channel modulator 4,5-dichloro-1,3-diethyl-1,3-dihydro-benzoimidazol-2-one (NS4591) on contractile force in rat, pig and human detrusor smooth muscle.
    Nielsen JS; Rode F; Rahbek M; Andersson KE; Rønn LC; Bouchelouche K; Nordling J; Bouchelouche P
    BJU Int; 2011 Sep; 108(5):771-7. PubMed ID: 21223472
    [TBL] [Abstract][Full Text] [Related]  

  • 13. (+/-)-Terodiline: an M1-selective muscarinic receptor antagonist. In vivo effects at muscarinic receptors mediating urinary bladder contraction, mydriasis and salivary secretion.
    Noronha-Blob L; Prosser JC; Sturm BL; Lowe VC; Enna SJ
    Eur J Pharmacol; 1991 Aug; 201(2-3):135-42. PubMed ID: 1724648
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effects of tiropramide hydrochloride on the isolated detrusor and intravesical pressure of the bladder in situ in rats].
    Uruno T; Murakami F; Wada K; Hizukuri M; Igarashi M; Yoshida K; Matsuoka Y; Sunagane N; Kubota K
    Nihon Yakurigaku Zasshi; 1992 Oct; 100(4):329-38. PubMed ID: 1446883
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacological effects of propiverine and its active metabolite, M-1, on isolated human urinary bladder smooth muscle, and on bladder contraction in rats.
    Sugiyama Y; Yoshida M; Masunaga K; Satoji Y; Maeda Y; Nagata T; Inadome A; Ueda S
    Int J Urol; 2008 Jan; 15(1):76-81. PubMed ID: 18184179
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of the anticholinergic drug prifinium bromide on urinary bladder contractions in rat in vivo and in guinea-pig in vitro.
    Terai T; Deguchi Y; Ohtsuka M; Kumada S
    Arzneimittelforschung; 1991 Apr; 41(4):417-20. PubMed ID: 1677577
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Agents for the treatment of overactive detrusor. I. Synthesis and structure-activity relationships of 1,1'-biphenyl derivatives.
    Take K; Okumura K; Takimoto K; Kato M; Ohtsuka M; Shiokawa Y
    Chem Pharm Bull (Tokyo); 1991 Nov; 39(11):2915-23. PubMed ID: 1799939
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Changes in urinary bladder smooth muscle function in response to colonic inflammation.
    Noronha R; Akbarali H; Malykhina A; Foreman RD; Greenwood-Van Meerveld B
    Am J Physiol Renal Physiol; 2007 Nov; 293(5):F1461-7. PubMed ID: 17715261
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of terflavoxate on stimulated contractions of urinary bladder in vitro.
    Testa R; Guarneri L; Bernasconi P; Angelico P; Ibba M; Poggesi E; Meli A
    Arzneimittelforschung; 1993 Feb; 43(2):122-8. PubMed ID: 8384453
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DPI-221 [4-((alpha-s)-alpha-((2s,5r)-2,5-dimethyl-4-(3-fluorobenzyl)-1-piperazinyl)benzyl)-N,N-diethylbenzamide]: a novel nonpeptide delta receptor agonist producing increased micturition interval in normal rats.
    Holt JD; Watson MJ; Chang JP; O'Neill SJ; Wei K; Pendergast W; Gengo PJ; Chang KJ
    J Pharmacol Exp Ther; 2005 Nov; 315(2):601-8. PubMed ID: 16020629
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.